日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Leukocytic ADAM10 and ADAM17 modulate disease severity and systemic outcome in bacterial and viral pneumonia

白细胞ADAM10和ADAM17调节细菌性和病毒性肺炎的疾病严重程度和全身预后。

Aljohmani, Ahmad; Herr, Christian; Witzenrath, Martin; Pätzold, Linda; Bischoff, Markus; Wartenberg, Philipp; Boehm, Ulrich; Beisswenger, Christoph; Tian, Qinghai; Laschke, Matthias W; Hannig, Matthias; Lehr, Claus-Michael; Bals, Robert; Schilling, Oliver; Yildiz, Daniela

METTL3 mediates m(6)A methylation of ADAM17 to Downregulate ACE2-Ang-(1-7) axis and promote progression of hypertension

METTL3介导ADAM17的m(6)A甲基化,从而下调ACE2-Ang-(1-7)轴并促进高血压的进展

Fei, Xuejie; Li, Caiyu; Bai, Jie; Xu, Yu; Hu, Ruihua; Wang, Xingxing; Pan, Yan; Zhu, Xinrui; Chen, Kequan; Chen, Aidong; Zhang, Lei; Han, Ying

Astrocytic Netrin-1 modulates stress-induced anxiety susceptibility in mice through ADAM17-mediated TNFα shedding.

星形胶质细胞 Netrin-1 通过 ADAM17 介导的 TNFα 脱落来调节小鼠应激诱导的焦虑易感性。

Yin Yue, Liu Xiu, Ma Jun, Liu Mei-Lin, Yi Lin-Sheng, Ni Jin-Ting, Xing Meng-Jie, Yang Jing, Tian Meng, Zhang Jia-Ai, Chen Wen-Bing, He Xiao-Xiao, He Zi-Xuan, Wang Ze-Zhong, Zhu Xiao-Juan, Yu Hua-Li

ADAM17, induced by Augmenter of Liver Regeneration via G protein-coupled receptor activation, transactivates epidermal growth factor-receptor and reduces classical IL-6 signaling.

ADAM17 是由肝脏再生增强剂通过 G 蛋白偶联受体激活诱导产生的,它能反式激活表皮生长因子受体,并减少经典的 IL-6 信号传导。

Voigt Christoph, Menzel Sophie, Dayoub Rania, Kubitza Marion, Schmutzler Florian, Buechler Christa, Eggenhofer Elke, Melter Michael, Weiss Thomas S

Mechanoresponsive ion channels Piezo1 and TRPV4 stimulate ADAM10 and ADAM17 with differential impact on endothelial migration and proliferation.

机械反应离子通道 Piezo1 和 TRPV4 刺激 ADAM10 和 ADAM17,对内皮细胞迁移和增殖产生不同的影响。

Pabst Alessa, Brock Nathalie, Hardt Sofie, Grannemann Caroline C F, Kubiza Hannah, Thiebes Anja Lena, Ludwig Andreas, Babendreyer Aaron

ADAM17-dependent Autocrine and Paracrine Signaling Promotes Pancreatic Premalignant Progression.

ADAM17依赖的自分泌和旁分泌信号促进胰腺癌前病变进展。

Wen Hui-Ju, Davis Erick T, Moore Jacee S, Brender Sydney M, Benitz Simone, Wombwell Allison M, Loveless Ian M, Long Daniel W, Salas-Escabillas Daniel J, Lee Justin, Devorkin Brian S, McQuithey Holly, Steele Nina G, Hurt Elaine, Crawford Howard C

Dual-functioning Targeted ADAM17 Blocker CD16 (TAB16) mediates selective ADAM17 inhibition in NK cells and engages overexpressed ADAM17 in tumor cells to induce cytotoxicity.

双功能靶向ADAM17阻断剂CD16(TAB16)介导NK细胞中ADAM17的选择性抑制,并与肿瘤细胞中过表达的ADAM17结合以诱导细胞毒性。

Dixon Kate J, Hullsiek Robert, Wang Sam, Friess Ryan R, Matson Anders W, Soignier Yvette, Lenvik Alexander J, Wu Jianming, Hart Geoffrey T, Felices Martin, Walcheck Bruce

ADAM17 Supports Disinhibition of Pre-sympathetic Glutamatergic Neurons Through Microglial Chemotaxis.

ADAM17 通过小胶质细胞趋化作用促进交感神经前谷氨酸能神经元的去抑制。

Wang Jiawei, Qiu Zihan, Han Yue, Wu Hanxue, Yuan Miao, Liu Yan, Wang Huichao, Yuan Shenglan, Gao Dengfeng, Sun Lina, Chen Xingjuan, Lazartigues Eric, Li Fanni, Yang Rui, Xu Jiaxi

IL‑37/IL‑1R8 blocks keratinocyte acantholysis via suppressing ADAM17/EGFR.

IL-37/IL-1R8 通过抑制 ADAM17/EGFR 来阻断角质形成细胞棘层松解。

Characterization of the D8P1C1 Anti-ADAM17 Inhibitory Monoclonal Antibody and Generation of Its Bispecific T-Cell Engager Derivative

D8P1C1 抗 ADAM17 抑制性单克隆抗体的特性分析及其双特异性 T 细胞衔接器衍生物的制备

Saha, Nayanendu; Lee, Sang Gyu; de Stanchina, Elisa; Mendoza, Rachelle P; Veach, Darren R; Nikolov, Dimitar B